Download PDF
Thromb Haemost 1995; 73(04): 728-729
DOI: 10.1055/s-0038-1653852
Letters to the Editor
Schattauer GmbH Stuttgart

Kinetic Behaviour of the TFPI and Anti-FXa Effects, after the Injection of a LMWH (RO-11) in Healthy Subjects

L Falkon
Unitat d’Hemostàsia i Trombosi, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
,
M Garí
Unitat d’Hemostàsia i Trombosi, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
,
D Sáenz-Campos
2   Dpto. Farmacología y Toxicología Clínica, Escuela de Medicina, Univ. de Costa Rica, Spain
,
R Antonijoan
1   Area d’lnvestigació Farmacològica, Institut de Recerca, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
,
M Barbanoj
1   Area d’lnvestigació Farmacològica, Institut de Recerca, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
,
J Fontcuberta
Unitat d’Hemostàsia i Trombosi, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
› Author Affiliations
Further Information

Publication History

Received 25 October 1994

Accepted after resubmission 04 January 1995

Publication Date:
26 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Broze Jr GJ, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII- tissue factor complex also inhibits factor Xa: Insight into its possible mechanism of action. Blood 1988; 71: 335-343
    PubMedGoogle Scholar
  • 2 Novotny WF, Girard TJ, Miletich JP, Broze Jr GJ. Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma. J Biol Chem 1989; 264: 18832-18837
    PubMedGoogle Scholar
  • 3 Novotny WF, Girard. Miletich JP, Broze Jr GJ. Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein-associated coagulation inhibitor. Blood 1988; 72: 2020-2025
    PubMedGoogle Scholar
  • 4 Sandset PM, Abildgaard U, Lie Larsen M. Heparin induces release of extrinsic coagulation pathway inhibitor (EPI). Thromb Res 1988; 50: 803-813
    CrossrefPubMedGoogle Scholar
  • 5 Bara L, Bloch MF, Zitoun D, Samama MM, Collignon F, Frydman A, Uzan A, Bouthier J. Comparative effects of enoxaparin and unfractionated heparin in healthy volunteers on prothrombin consumption in whole blood during coagulation, and release of tissue factor pathway inhibition. Thromb Res 1993; 69: 443-452
    CrossrefPubMedGoogle Scholar
  • 6 Wun T-C. Lipoprotein-associated coagulation inhibitor (LACI) is a cofactor for heparin: synergistic anticoagulant action between LACI and sulfated polysaccharides. Blood 1992; 79: 430-438
    PubMedGoogle Scholar
  • 7 Sandset PM, Abildgaard U, Petterssen M. A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions. Thromb Res 1987; 47: 489-500
    PubMedGoogle Scholar
  • 8 Yamaoka K, Naragawa T, Uno T. Statistical moments in pharmacokinetics. J Pharmacokin Biopharm 1978; 6: 547-558
    PubMedGoogle Scholar
  • 9 Ariëns RA S, Faioni EM, Mannucci PM. Repeated release of the tissue factor pathway inhibitor. Thromb Haemost 1994; 72: 327-328
    Article in Thieme ConnectPubMedGoogle Scholar